214 related articles for article (PubMed ID: 36733699)
1. Deep-learning based approach to identify substrates of human E3 ubiquitin ligases and deubiquitinases.
Shu Y; Hai Y; Cao L; Wu J
Comput Struct Biotechnol J; 2023; 21():1014-1021. PubMed ID: 36733699
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases.
Celebi G; Kesim H; Ozer E; Kutlu O
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882786
[TBL] [Abstract][Full Text] [Related]
3. Targeting E3 ubiquitin ligases for cancer therapy.
Sun Y
Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
[TBL] [Abstract][Full Text] [Related]
4. E3-ubiquitin ligases and recent progress in osteoimmunology.
Asano Y; Matsumoto Y; Wada J; Rottapel R
Front Immunol; 2023; 14():1120710. PubMed ID: 36911671
[TBL] [Abstract][Full Text] [Related]
5. UbiNet 2.0: a verified, classified, annotated and updated database of E3 ubiquitin ligase-substrate interactions.
Li Z; Chen S; Jhong JH; Pang Y; Huang KY; Li S; Lee TY
Database (Oxford); 2021 Mar; 2021():. PubMed ID: 33693667
[TBL] [Abstract][Full Text] [Related]
6. Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3. Targeting of protein substrates via multiple and distinct recognition signals and conjugating enzymes.
Gonen H; Stancovski I; Shkedy D; Hadari T; Bercovich B; Bengal E; Mesilati S; Abu-Hatoum O; Schwartz AL; Ciechanover A
J Biol Chem; 1996 Jan; 271(1):302-10. PubMed ID: 8550577
[TBL] [Abstract][Full Text] [Related]
7. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
8. A protein sequence-based deep transfer learning framework for identifying human proteome-wide deubiquitinase-substrate interactions.
Liu Y; Li D; Zhang X; Xia S; Qu Y; Ling X; Li Y; Kong X; Zhang L; Cui CP; Li D
Nat Commun; 2024 May; 15(1):4519. PubMed ID: 38806474
[TBL] [Abstract][Full Text] [Related]
9. Current and future directions of USP7 interactome in cancer study.
Park HB; Baek KH
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188992. PubMed ID: 37775071
[TBL] [Abstract][Full Text] [Related]
10. Functional diversity and structural disorder in the human ubiquitination pathway.
Bhowmick P; Pancsa R; Guharoy M; Tompa P
PLoS One; 2013; 8(5):e65443. PubMed ID: 23734257
[TBL] [Abstract][Full Text] [Related]
11. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network.
Li Y; Xie P; Lu L; Wang J; Diao L; Liu Z; Guo F; He Y; Liu Y; Huang Q; Liang H; Li D; He F
Nat Commun; 2017 Aug; 8(1):347. PubMed ID: 28839186
[TBL] [Abstract][Full Text] [Related]
12. The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy.
Wang X; Zhang Y; Wu Y; Cheng H; Wang X
Front Immunol; 2023; 14():1202633. PubMed ID: 37215134
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinases in cancer.
Dewson G; Eichhorn PJA; Komander D
Nat Rev Cancer; 2023 Dec; 23(12):842-862. PubMed ID: 37935888
[TBL] [Abstract][Full Text] [Related]
14. Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.
Bushman JW; Donovan KA; Schauer NJ; Liu X; Hu W; Varca AC; Buhrlage SJ; Fischer ES
Cell Chem Biol; 2021 Jan; 28(1):78-87.e3. PubMed ID: 33007217
[TBL] [Abstract][Full Text] [Related]
15. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species.
Wang X; Li Y; He M; Kong X; Jiang P; Liu X; Diao L; Zhang X; Li H; Ling X; Xia S; Liu Z; Liu Y; Cui CP; Wang Y; Tang L; Zhang L; He F; Li D
Nucleic Acids Res; 2022 Jan; 50(D1):D719-D728. PubMed ID: 34669962
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system.
van Wijk SJ; de Vries SJ; Kemmeren P; Huang A; Boelens R; Bonvin AM; Timmers HT
Mol Syst Biol; 2009; 5():295. PubMed ID: 19690564
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligases: styles, structures and functions.
Yang Q; Zhao J; Chen D; Wang Y
Mol Biomed; 2021 Jul; 2(1):23. PubMed ID: 35006464
[TBL] [Abstract][Full Text] [Related]
18. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
19. Identification and Analysis of Subtypes of Liver Cancer Based on Genes Related to E3 Ubiquitin Ligases and Deubiquitinating Enzymes.
Hu Y; Huang P; Jiang F
Tohoku J Exp Med; 2024 Feb; 262(2):75-84. PubMed ID: 37880130
[TBL] [Abstract][Full Text] [Related]
20. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics.
Antao AM; Tyagi A; Kim KS; Ramakrishna S
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
